Aegis Capital Corp. acted as Sole Bookrunner on a $10.0 Million Underwritten Public Offering for Sunshine Biopharma, Inc.
New York, New York / GLOBE NEWSWIRE/ February 15, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $10.0 Million Underwritten...